Enjoy the ride, page-16

Don't know the answer I'm afraid DD. My point was slightly different -- have these programs cost us $40-45m after allowing for the tax credits? Anyway, $40m in cash/upfront, or even half that, (leave aside pie-in-the sky milestones/royalties) is more than I was expecting for these oncology "assets" and I will not believe it until there is an ASX announcement confirming the agreement. If these assets are to be sold before end of financial year (as we have been led to believe) then we should know soon enough.